Is 3D Printing of Pharmaceuticals a Disruptor or Enabler?,Advanced Materials

当前位置： X-MOL 学术 › Adv. Mater. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Is 3D Printing of Pharmaceuticals a Disruptor or Enabler?
Advanced Materials ( IF 27.4 ) Pub Date : 2018-12-03 , DOI: 10.1002/adma.201805680
Kun Liang ₁ , Davide Brambilla ₂ , Jean-Christophe Leroux ₃

Affiliation

Additive manufacturing (AM) is a fast‐growing manufacturing approach that comes with the promise of delivering personalized medicine to treat individual patients. However, large‐scale commercial applications in the pharmaceutical industry have been limited. Here, some of the challenges are discussed along with some pharmaceutical products where AM has the potential to make a tangible impact and pave the way for more rapid adoption are highlighted.

中文翻译：